{"address1": "9704 Medical Center Drive", "city": "Rockville", "state": "MD", "zip": "20850", "country": "United States", "phone": "301 251 5172", "fax": "301 251 5321", "website": "https://www.macrogenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics to treat cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint inhibitors PD-1 and CTLA-4 for the treatment of mCRPC and docetaxel that is in phase 2 clinical trials, as well as for the treatment of platinum-resistant ovarian cancer and clear cell gynecologic cancer which has completed phase 1 clinical trial; MGC026, an ADC that targets B7-H3 and delivers a novel topoisomerase I inhibitor (TOP1i)-based linker-payload; MGC028, an antibody-drug conjugates (ADC) that targets ADAM9 and delivers a novel TOP1i-based linker-payload for the treatment of solid tumors, which is in phase 1 clinical trials; MGC030, a ADC molecule for the treatment of solid tumors, which is in preclinical trials. It is also developing next generation T-cell engager programs. The company has collaborations with TerSera Therapeutics LLC; Incyte Corporation; and Gilead Sciences, Inc. MacroGenics, Inc. was incorporated in 2000 and is headquartered in Rockville, Maryland.", "fullTimeEmployees": 341, "companyOfficers": [{"maxAge": 1, "name": "Dr. Scott  Koenig M.D., Ph.D.", "age": 72, "title": "President, CEO & Director", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 1199494, "exercisedValue": 0, "unexercisedValue": 459000}, {"maxAge": 1, "name": "Mr. James  Karrels", "age": 57, "title": "Senior VP, CFO & Corporate Secretary", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 693306, "exercisedValue": 0, "unexercisedValue": 162000}, {"maxAge": 1, "name": "Dr. Stephen L. Eck M.D., Ph.D.", "age": 69, "title": "Senior VP of Clinical Development & Chief Medical Officer", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 766848, "exercisedValue": 0, "unexercisedValue": 180000}, {"maxAge": 1, "name": "Mr. Eric Blasius Risser", "age": 51, "title": "Chief Operating Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 651362, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Thomas M. Spitznagel Ph.D.", "age": 57, "title": "Senior Vice President of Technical Operations", "yearBorn": 1967, "fiscalYear": 2023, "totalPay": 550974, "exercisedValue": 204497, "unexercisedValue": 490417}, {"maxAge": 1, "name": "Dr. Ezio  Bonvini M.D.", "age": 70, "title": "Senior VP of Research & Chief Scientific Officer", "yearBorn": 1954, "fiscalYear": 2023, "totalPay": 612208, "exercisedValue": 264031, "unexercisedValue": 199063}, {"maxAge": 1, "name": "Mr. Jeffrey Stuart Peters J.D.", "age": 53, "title": "Senior VP, General Counsel & Corporate Compliance Officer", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Beth  Smith", "title": "VP, Controller & Treasurer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 5, "boardRisk": 3, "compensationRisk": 6, "shareHolderRightsRisk": 7, "overallRisk": 5, "governanceEpochDate": 1743465600, "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.27, "open": 1.26, "dayLow": 1.17, "dayHigh": 1.299, "regularMarketPreviousClose": 1.27, "regularMarketOpen": 1.26, "regularMarketDayLow": 1.17, "regularMarketDayHigh": 1.299, "payoutRatio": 0.0, "beta": 2.108, "forwardPE": -0.50622404, "volume": 955709, "regularMarketVolume": 955709, "averageVolume": 696353, "averageVolume10days": 1068450, "averageDailyVolume10Day": 1068450, "bid": 1.17, "ask": 1.27, "bidSize": 1, "askSize": 2, "marketCap": 76970168, "fiftyTwoWeekLow": 1.17, "fiftyTwoWeekHigh": 19.541, "priceToSalesTrailing12Months": 0.5132645, "fiftyDayAverage": 2.4466, "twoHundredDayAverage": 3.425325, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -87235808, "profitMargins": -0.44654998, "floatShares": 52340363, "sharesOutstanding": 63090300, "sharesShort": 4972906, "sharesShortPriorMonth": 5523754, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.0788, "heldPercentInsiders": 0.02247, "heldPercentInstitutions": 0.93318003, "shortRatio": 8.94, "shortPercentOfFloat": 0.096599996, "impliedSharesOutstanding": 63090300, "bookValue": 1.847, "priceToBook": 0.6605306, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -66966000, "trailingEps": -1.07, "forwardEps": -2.41, "enterpriseToRevenue": -0.582, "enterpriseToEbitda": 0.847, "52WeekChange": -0.9107535, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.22, "targetHighPrice": 8.0, "targetLowPrice": 2.0, "targetMeanPrice": 5.8, "targetMedianPrice": 6.0, "recommendationMean": 2.44444, "recommendationKey": "buy", "numberOfAnalystOpinions": 5, "totalCash": 201667008, "totalCashPerShare": 3.196, "ebitda": -103038000, "totalDebt": 37461000, "quickRatio": 3.709, "currentRatio": 3.917, "totalRevenue": 149962000, "debtToEquity": 32.278, "revenuePerShare": 2.395, "returnOnAssets": -0.24679, "returnOnEquity": -0.4985, "grossProfits": -39531000, "freeCashflow": -32491124, "operatingCashflow": -68373000, "revenueGrowth": 0.805, "grossMargins": -0.26361, "ebitdaMargins": -0.68709, "operatingMargins": -2.73017, "financialCurrency": "USD", "symbol": "MGNX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "MacroGenics, Inc.", "longName": "MacroGenics, Inc.", "corporateActions": [], "preMarketTime": 1743595202, "regularMarketTime": 1743537602, "exchange": "NMS", "messageBoardId": "finmb_600911", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.937004, "regularMarketPrice": 1.22, "marketState": "PRE", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 696353, "fiftyTwoWeekLowChange": 0.05000007, "fiftyTwoWeekLowChangePercent": 0.042735107, "fiftyTwoWeekRange": "1.17 - 19.541", "fiftyTwoWeekHighChange": -18.321001, "fiftyTwoWeekHighChangePercent": -0.9375672, "fiftyTwoWeekChangePercent": -91.07535, "earningsTimestamp": 1742500800, "earningsTimestampStart": 1746615540, "earningsTimestampEnd": 1747051200, "earningsCallTimestampStart": 1742502600, "earningsCallTimestampEnd": 1742502600, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.07, "epsForward": -2.41, "epsCurrentYear": -2.89, "priceEpsCurrentYear": -0.42214534, "fiftyDayAverageChange": -1.2265999, "fiftyDayAverageChangePercent": -0.5013488, "twoHundredDayAverageChange": -2.205325, "twoHundredDayAverageChangePercent": -0.6438294, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "2.4 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1381411800000, "preMarketChange": 0.0, "preMarketChangePercent": 0.0, "preMarketPrice": 1.22, "regularMarketChange": -0.049999952, "regularMarketDayRange": "1.17 - 1.299", "displayName": "MacroGenics", "trailingPegRatio": null}